Product Highlight: Ligand Binding Assays for GLP-1 analogs (Peptide Drugs) in line with FDA Considerations Background: Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. The mechanism of the GLP-1 analogs is to prevent the breakdown of GLP-1. This enhances […]
